Transarterial Chemoembolization Plus Lenvatinib and PD-1 Inhibitors for Hepatocellular Carcinoma with Main Trunk Portal Vein Tumor Thrombus: A Multicenter Retrospective Study

Shu-Qun Li,1– 3,* Jun-Yi Wu,1,2,* Jia-Yi Wu,1,2,* Huang Xie,4,* Jin-Hai Li,1,2 Zhen-Xin Zeng,1,2 Yang-Kai Fu,1,2 De-Yi Liu,1,2 Han Li,1,2 Wei-Zhao Chen,1,2 Jing-Yao Huang,4 Mao-Lin Yan1,2 1Department of Hepatobiliary Pancreatic Surgery, Shengli Clinical Medical College of Fujian Medi...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Li SQ, Wu JY, Xie H, Li JH, Zeng ZX, Fu YK, Liu DY, Li H, Chen WZ, Huang JY, Yan ML
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Dove Medical Press 2023-10-01
Colecção:	Journal of Hepatocellular Carcinoma
Assuntos:	transarterial chemoembolization lenvatinib programmed death 1 inhibitor hepatic cellular carcinoma main trunk portal vein triple therapy.
Acesso em linha:	https://www.dovepress.com/transarterial-chemoembolization-plus-lenvatinib-and-pd-1-inhibitors-fo-peer-reviewed-fulltext-article-JHC
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!